Australian-based medicinal cannabis producer Cannim has unveiled its debut product, Lumir.
Named after Professor Lumir Hanus, an analytical chemist from the Czech Republic who has been studying cannabis for more than 50 years, the tinctures are the first of a number of products Cannim will launch under the Lumir brand. Manufactured in Australia, Lumir is available in three 30ml tincture formulas – 10:10, THC27 and CBD50.
Cannim’s founder John Worton said: “Professor Hanus is a key member of our advisory board and we are proud to be able to honour him in this way, whilst adding a compelling and high-quality new product range to Australia’s rapidly growing medicinal cannabis market.”
Cannim has also struck a two-year deal with Burleigh Heads Cannabis to give physicians and consumers access to the Lumir range via BHC’s ordering technology platform CanView under the Special Access Scheme.
MediPharm Labs Australia recently signed a GMP white-label supply and contract manufacturing agreement with Cannim.
